Labcorp Shares Outstanding 2010-2024 | LH

Labcorp shares outstanding history from 2010 to 2024. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
  • Labcorp shares outstanding for the quarter ending March 31, 2024 were 0.085B, a 4.83% decline year-over-year.
  • Labcorp 2023 shares outstanding were 0.088B, a 4.37% decline from 2022.
  • Labcorp 2022 shares outstanding were 0.092B, a 6.05% decline from 2021.
  • Labcorp 2021 shares outstanding were 0.098B, a 0.51% decline from 2020.
Labcorp Annual Shares Outstanding
(Millions of Shares)
2023 88
2022 92
2021 98
2020 98
2019 99
2018 103
2017 104
2016 104
2015 101
2014 86
2013 92
2012 97
2011 102
2010 105
2009 109
Labcorp Quarterly Shares Outstanding
(Millions of Shares)
2024-03-31 85
2023-12-31 88
2023-09-30 87
2023-06-30 89
2023-03-31 89
2022-12-31 92
2022-09-30 91
2022-06-30 93
2022-03-31 94
2021-12-31 98
2021-09-30 97
2021-06-30 98
2021-03-31 99
2020-12-31 98
2020-09-30 98
2020-06-30 98
2020-03-31 97
2019-12-31 99
2019-09-30 98
2019-06-30 99
2019-03-31 100
2018-12-31 103
2018-09-30 103
2018-06-30 103
2018-03-31 103
2017-12-31 104
2017-09-30 104
2017-06-30 104
2017-03-31 104
2016-12-31 104
2016-09-30 105
2016-06-30 104
2016-03-31 104
2015-12-31 101
2015-09-30 103
2015-06-30 103
2015-03-31 94
2014-12-31 86
2014-09-30 87
2014-06-30 86
2014-03-31 87
2013-12-31 92
2013-09-30 91
2013-06-30 94
2013-03-31 95
2012-12-31 97
2012-09-30 97
2012-06-30 98
2012-03-31 99
2011-12-31 102
2011-09-30 102
2011-06-30 103
2011-03-31 103
2010-12-31 105
2010-09-30 104
2010-06-30 105
2010-03-31 107
2009-12-31 109
2009-09-30 109
2009-06-30 110
2009-03-31 109
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $18.190B $12.162B
Laboratory Corporation of America Holdings or LabCorp is a leading healthcare diagnostics company, providing comprehensive clinical laboratory services and end-to-end drug development support. The provide vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $75.631B 21.23
Becton Dickinson (BDX) United States $67.642B 19.14
West Pharmaceutical Services (WST) United States $23.823B 42.69
Cardinal Health (CAH) United States $23.375B 13.37
Align Technology (ALGN) United States $18.864B 36.42
Cooper (COO) United States $18.112B 26.71
Henry Schein (HSIC) United States $9.120B 16.22
DENTSPLY SIRONA (XRAY) United States $5.718B 14.81
Merit Medical Systems (MMSI) United States $5.034B 27.59
Patterson (PDCO) United States $2.315B 11.42
CONMED (CNMD) United States $2.267B 20.56
STAAR Surgical (STAA) United States $2.173B 83.45
Atrion (ATRI) United States $0.803B 42.90
Lifevantage (LFVN) United States $0.081B 10.51
Pro-Dex (PDEX) United States $0.068B 34.31